Cite

1. Atkinson V. Recent advances in malignant melanoma. Intern Med J 2017; 47(10):1114–21.10.1111/imj.1357428994264Search in Google Scholar

2. Longvert C, Saiag P. Melanoma update. Rev Med Interne 2019; 40(3): 178–83.10.1016/j.revmed.2018.11.00530527396Search in Google Scholar

3. Cabrera R, Recule F. Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings. Am J Clin Dermatol 2018; 1: 15–23.10.1007/s40257-018-0373-6624463530374898Search in Google Scholar

4. Pavri SN, Clune J, Ariyan S, Narayan D. Malignant melanoma: beyond the basics. Plast Reconstr Surg 2016; 138(2): 330e–340e.10.1097/PRS.000000000000236727465194Search in Google Scholar

5. Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: from pathogenesis to therapy. Int J Oncol. 2018; 52: 1071–80.10.3892/ijo.2018.4287584339229532857Search in Google Scholar

6. Hartman RI, Lin JY. Cutaneous melanoma-a review in detection, staging, and management. Hematol Oncol Clin North Am 2019; 33(1): 25–38.10.1016/j.hoc.2018.09.00530497675Search in Google Scholar

7. Iglesias-Pena N, Paradela S, Tejera-Vaquerizo A, Boada A, Fonseca E. Cutaneous melanoma in the elderly: review of a growing problem. Actas Dermosifiliogr 2019; 110: 434–47.10.1016/j.ad.2018.11.00931101317Search in Google Scholar

8. Takano T. Natural history of thyroid cancer. Endocr J 2017; 64: 237–44.10.1507/endocrj.EJ17-002628154351Search in Google Scholar

9. Luzón-Toro B, Fernández RM, Villalba-Benito L, Torroglosa A, Antiñolo G, Borrego S. Influencers on thyroid cancer onset: molecular genetic basis. Genes (Basel) 2019; 10: 913.10.3390/genes10110913689580831717449Search in Google Scholar

10. Albi E, Cataldi S, Lazzarini A, Codini M, Beccari T, Ambesi-Impiombato FS, et al. Radiation and Thyroid Cancer. Int J Mol Sci 2017; 18: 911.10.3390/ijms18050911545482428445397Search in Google Scholar

11. Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol 2018; 14: 670–83.10.1038/s41574-018-0080-730131586Search in Google Scholar

12. Ferrari SM, Fallahi P, Elia G, Ragusa F, Ruffilli I, Paparo SR, et al. Thyroid autoimmune disorders and cancer. Semin Cancer Biol 2020; 64: 135–46.10.1016/j.semcancer.2019.05.01931158464Search in Google Scholar

13. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010; 174: 741–5210.1667/RR2240.1308002321128798Search in Google Scholar

14. Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol 2012; 19: 1887–96.10.1245/s10434-011-2193-2437219522227921Search in Google Scholar

15. Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018; 18: 269–82.10.1038/nrc.2018.1129497144Search in Google Scholar

16. Hahn LD, Kunder CA, Chen MM, Orloff LA, Desser TS. Indolent thyroid cancer: knowns and unknowns. Cancers Head Neck 2017; 2: 1.10.1186/s41199-016-0021-x646073231093348Search in Google Scholar

17. Serafini MS, Lopez-Perez L, Fico G, Licitra L, De Cecco L, Resteghini C. Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures. Cancers Head Neck 2020; 5: 2.10.1186/s41199-020-0047-y697187131988797Search in Google Scholar

18. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 2017; 112: 136–52.10.1016/j.critrevonc.2017.01.01928325255Search in Google Scholar

19. Nenclares P, Ap Dafydd D, Bagwan I, Begg D, Kerawala C, King E, et al. Head and neck mucosal melanoma: The United Kingdom national guidelines. Eur J Cancer 2020; 138: 11–18.10.1016/j.ejca.2020.07.01732829104Search in Google Scholar

20. Green B, Elhamshary A, Gomez R, Rahimi S, Brennan PA. An update on the current management of head and neck mucosal melanoma. J Oral Pathol Med 2017; 46: 475–79.10.1111/jop.1252627864904Search in Google Scholar

21. Jaballah Vinckenbosch P, Litzistorf Y, Gaide O, Özdemir BC, Michielin O, Reinhard A. ENT management of head and neck cutaneous melanoma. Rev Med Suisse 2020; 16: 1853–59.Search in Google Scholar

22. Lerner BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal melanoma: new insights and therapeutic options for a unique and aggressive disease. Oncology 2017; 31: e23–e32.Search in Google Scholar

23. Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012; 5: 739-53.Search in Google Scholar

24. Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, et al. Papillary thyroid cancer- aggressive variants and impact on management: a narrative review. Adv Ther 2020; 37: 3112–28.10.1007/s12325-020-01391-1746741632488657Search in Google Scholar

25. Haroon Al Rasheed MR, Xu B. Molecular alterations in thyroid carcinoma. Surg Pathol Clin 2019; 12: 921–30.10.1016/j.path.2019.08.002688392331672298Search in Google Scholar

26. Costa MM, Belo S, Capela-Costa J, Costa J, Carvalho D. Malignant melanoma with synchronous thyroid metastases: case report and literature review. Arch Endocrinol Metab 2017; 61: 193–97.10.1590/2359-399700000025128225857Search in Google Scholar

27. Heroiu Cataloiu AD, Danciu CE, Popescu CR. Multiple cancers of the head and neck. Maedica (Bucur) 2013; 8 : 80–85.Search in Google Scholar

28. Miccoli P, Bakkar S. Surgical management of papillary thyroid carcinoma: an overview. Updates Surg. 2017; 69:145–50.10.1007/s13304-017-0449-528405952Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other